HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Depression of normal lymphocyte transformation by sera of patients with minimal change nephropathy and other forms of nephrotic syndrome.

Abstract
Sera from patients with the nephrotic syndrome due to minimal change nephropathy (11 patients), membranous nephropathy (14 patients) and focal glomerulosclerosis (15 patients) inhibited the response of normal lymphocytes to the mitogen Concanavalin A. Although there was a tendency for the sera of patients with minimal change nephropathy to be more inhibitory than sera from the other two forms of nephrotic syndrome, this effect of nephrotic sera on normal lymphocytes is not confined to minimal change nephropathy. Until the exact nature of the inhibitor(s) is established, it is therefore not possible to state that impaired lymphocyte transformation by serum plays a pathogenetic role specifically in minimal change nephropathy. The susceptibility of nephrotic patients to infection may be due in part to the sera of the patients causing reduced lymphocyte function in vivo which leads to a defective immune response.
AuthorsD Taube, S Chapman, Z Brown, D G Williams
JournalClinical nephrology (Clin Nephrol) Vol. 15 Issue 6 Pg. 286-90 (Jun 1981) ISSN: 0301-0430 [Print] Germany
PMID7249426 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Concanavalin A
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Concanavalin A (pharmacology)
  • Glomerulosclerosis, Focal Segmental (blood, immunology)
  • Humans
  • Lymphocyte Activation
  • Middle Aged
  • Nephrosis, Lipoid (blood, immunology)
  • Nephrotic Syndrome (blood, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: